Advanced Centre for Treatment, Research and Education in Cancer

What Advanced Centre for Treatment, Research and Education in Cancer does

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is a government-funded cancer treatment, research, and education institution operating as the R&D wing of the Tata Memorial Centre (TMC). Established in 1984 as the Cancer Research Institute (CRI) under founding director Dr. V.R. Khanolkar, ACTREC is located in Kharghar, Navi Mumbai, at the foothills of the Sahyadri mountains, and is administered as a grant-in-aid institution under India's Department of Atomic Energy. The current Director is Dr. Pankaj Chaturvedi.

ACTREC's service portfolio integrates three pillars. Clinically, it operates more than 20 specialty departments (medical oncology, surgical oncology, radiation oncology, anesthesiology, pathology, hematopathology, palliative medicine, nuclear medicine, etc.) and 11 Disease Management Groups covering adult and pediatric cancers, supported by a Proton Therapy Center and a Phase I Clinical Trials Unit. In research, ACTREC spans basic research (cancer cell biology, genomics, proteomics, tumor immunology, immunotherapy, stem cell biology, theranostics) and translational research (clinical genomics, molecular hematology, neuro-oncology, molecular pathology, radiobiology), supported by the collaborative TMC-MIZUHO Research Laboratories and a Cancer Research Library. In education, ACTREC delivers PhD and fellowship programs through Homi Bhabha National Institute (HBNI) affiliation, including Junior Research Fellow (JRF) selections and HBNI clinical fellowships.

Commercially, ACTREC's revenue mix consists of government grant-in-aid funding from the Department of Atomic Energy (core funding), clinical services revenue from patients at subsidized rates for Indian citizens and full-cost rates for international patients, and academic fees from PhD/fellowship programs. Pricing is unit-based, publicly disclosed via the Schedule of Charges, and billed pay-as-you-go. Patient acquisition is community-led, flowing through physician referrals across the TMC network (TMC Mumbai, TMH Varanasi, HBCHRC Vishakhapatnam, BBCI Guhawati, etc.), online registration via ABHA, the EMR mobile app (Android/iOS), and the Navya.care online expert opinion service for telemedicine second opinions. No disclosed headcount, revenue, or funding-round data exists in the source material.

Name

Advanced Centre for Treatment, Research and Education in Cancer

Legal name

Tata Memorial Centre Advanced Centre for Treatment, Research & Education in Cancer

Website

https://actrec.gov.in

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

101–250 employees

Short description

ACTREC is a government-funded cancer treatment, research, and education institution serving as the R&D wing of India's Tata Memorial Centre, delivering clinical oncology, basic/translational research, and HBNI-affiliated academic programs to adult and pediatric cancer patients across India.

Ownership category

akta.pro rank

Product category

Cancer Treatment and Research

NAICS

Offices of Physicians (6211), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Cancer treatment services
• Oncology research
• Radiation oncology
• Proton therapy
• Clinical trials oncology

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain

Revenue model

1. Clinical Services Revenue: Revenue generated from patient treatment services including outpatient and inpatient care, diagnostic services, and therapeutic treatments. As a government-funded institution under the Department of Atomic Energy, a significant portion of operations is supported by government grants.
2. Government Funding: ACTREC is a grant-in-aid institution under the Department of Atomic Energy, Government of India, providing core operational funding for research and treatment activities.
3. Education and Training Programs: Revenue from academic programs including PhD fellowships (JRF), medical training, and continuing education for healthcare professionals.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

ACTREC provides comprehensive cancer treatment across 11 Disease Management Groups (including breast, GI, head & neck, neuro-oncology, thoracic, pediatric, and hemato-lymphoid), supported by medical, surgical, and radiation oncology departments plus a Proton Therapy Center. It conducts basic, translational, and clinical cancer research spanning genomics, proteomics, tumor immunology, immunotherapy, and theranostics, and runs academic programs including PhD, JRF, and HBNI fellowships in life and health sciences.

Product overview

ACTREC (Advanced Centre for Treatment, Research and Education in Cancer) is a comprehensive cancer care and research institution operating as the R&D wing of Tata Memorial Centre. The organization operates a unified platform combining clinical treatment services, basic and translational research programs, and academic education. The core offerings include specialized cancer treatment across multiple disease management groups (medical, surgical, radiation oncology), advanced proton therapy, clinical trial capabilities, PhD/fellowship academic programs, and patient-facing digital tools including EMR mobile apps. Research activities span from basic biomolecular studies to precision medicine and immunotherapy, supported by specialized facilities including the TMC-MIZUHO Research Laboratories and a comprehensive cancer research library.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Treatment and Clinical Services

Quantifiable outcome

• 18.1 million new cancer cases, 9.6 million cancer deaths worldwide in 2018 (IARC data) - highlighting the critical need for cancer research centers
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Tata Memorial Centre (Parent Organization)coreStrategic or Co-development PartnerACTREC is the R&D wing of Tata Memorial Centre. The partnership involves integrated research, clinical services, and educational programs across the TMC network including multiple hospital locations.
• TMC-MIZUHO Research LaboratoriescoreStrategic or Co-development PartnerCollaborative research laboratory facility for advanced cancer research, combining resources for cutting-edge oncology research.
• Homi Bhabha National Institute (HBNI)coreStrategic or Co-development PartnerAcademic affiliation for PhD and fellowship programs. ACTREC conducts JRF (Junior Research Fellow) selections and HBNI fellowship programs in life sciences and health sciences.
• Tata Memorial Centre Network HospitalscoreStrategic or Co-development PartnerIntegrated network including TMC Mumbai, TMH Mumbai, CCE Mumbai, HBCH Varanasi, HBCH Sangrur, HBCHRC Vishakhapatnam, BBCI Guhawati for referral and collaborative patient care.
• Scientific Societies (IACR, MIG, India Bioscience, ISBC, EMSI, Brain Tumor Foundation of India)minorOthersMembership and collaboration with scientific societies for cancer research networking and professional development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• European Institute of Oncology (IEO): Leading European cancer research and treatment institution combining clinical care with translational research. Comparable as an integrated cancer center with strong research arm and academic training programs.
• MD Anderson Cancer Center: World-leading comprehensive cancer center in the US combining multi-disciplinary patient care, research, and education. Comparable as a globally renowned integrated cancer treatment and research institution with academic/training programs.
• Memorial Sloan Kettering Cancer Center: Premier US cancer center with integrated clinical care, research, and training. Comparable as a comprehensive academic cancer center with multi-disciplinary disease management groups and translational research programs.

Direct peers

• Cancer Institute (WIA), Chennai: One of India's oldest dedicated cancer treatment and research institutions, offering comprehensive cancer care with research and training programs. Comparable as a long-standing Indian cancer hospital with combined clinical, research, and academic mandate.
• Tata Memorial Hospital: ACTREC's parent organization and the flagship clinical hospital of the Tata Memorial Centre network. Directly comparable as India's premier public cancer treatment institution, sharing identical governance under Department of Atomic Energy and integrated clinical-research-education mandate.
• Rajiv Gandhi Cancer Institute and Research Centre: Leading tertiary cancer care center in Delhi NCR offering comprehensive oncology services across medical, surgical, and radiation oncology. Comparable as a multi-disciplinary cancer hospital with research and academic programs serving Indian patients.
• Apollo Cancer Centre: Apollo Hospitals' dedicated cancer care network across India offering medical, surgical, and radiation oncology with proton therapy capabilities. Comparable as a comprehensive cancer care provider with advanced technology and multi-specialty oncology services.
• AIIMS (All India Institute of Medical Sciences) - Oncology: Premier government medical institution with a major oncology department providing cancer treatment, research, and academic training. Comparable as a government-funded institution delivering affordable cancer care with academic and research programs.
• HCG (HealthCare Global Enterprises): Largest cancer care network in India with comprehensive oncology services across multiple hospitals. Comparable as a pan-India cancer specialty provider offering medical, surgical, radiation oncology, and advanced treatment modalities.
• Tata Medical Center (Kolkata): Tata Group's dedicated cancer hospital in Kolkata offering comprehensive oncology services. Comparable as a Tata-affiliated cancer institution with similar mission of affordable cancer care, research, and training.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CRI_ACTREC
• YouTubeyoutube.com/channel/UCbjc1WadObMdvt8x_bByVmA
• Facebookfacebook.com/ACTRECTMC
• LinkedInlinkedin.com/company/advanced-centre-for-treatment-research-and-education-in-cancer-actrec

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Centre for Treatment, Research and Education in Cancer